These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


193 related items for PubMed ID: 1007172

  • 1. [Use of liver hydrolysates and corticosteroids in chronic hepatitis and liver cirrhosis].
    Bakulenko EF.
    Vrach Delo; 1976 Apr; (4):108-10. PubMed ID: 1007172
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Effect of complex therapy on the electrolyte metabolism in patients with chronic hepatitis and liver cirrhosis].
    Rudyk BI.
    Vrach Delo; 1973 Sep; 9():89-93. PubMed ID: 4768488
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Inquiries on the etiology, pathogenesis, therapeutic successes and survival time in a random group of 560 patients with liver cirrhosis].
    Creutzfeldt W, Beck K.
    Dtsch Med Wochenschr; 1966 Apr 15; 91(15):682-9. PubMed ID: 5932096
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Long-term treatment of chronic aggressive hepatitis and liver cirrhosis using immunosuppressive agents].
    Bannaski H.
    Med Welt; 1974 Sep 27; 25(39):1551-5. PubMed ID: 4427553
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Trofopar treatment of chronic diffuse diseases of the liver].
    Loginov AS, Nikolaeva AP, Bendikov EA, Blok IuE, Sukhareva GV.
    Sov Med; 1989 Sep 27; (7):79-81. PubMed ID: 2799537
    [No Abstract] [Full Text] [Related]

  • 12. [Immunosuppressive therapy of inflammatory liver diseases].
    Meyer zum Büschenfelde, Perings E, Crettzfeldt W.
    Ther Umsch; 1971 Sep 27; 28(9):586-95. PubMed ID: 5122521
    [No Abstract] [Full Text] [Related]

  • 13. Studies on the effect of a liver hydrolysate on the hepatic circulation in chronic liver diseases.
    Obayashi A, Akioka H, Tazaki H.
    Arzneimittelforschung; 1972 Mar 27; 22(3):578-80. PubMed ID: 5067932
    [No Abstract] [Full Text] [Related]

  • 14. The natural history of hepatitis-associated (Australia)-antigen (HAA)-positive chronic liver disease.
    Dudley FJ, Scheuer PJ, Sherlock S.
    Gut; 1972 Oct 27; 13(10):852. PubMed ID: 5087111
    [No Abstract] [Full Text] [Related]

  • 15. [Immunoprevention and immunosuppression of chronic inflammatory liver diseases].
    Scheiffarth F.
    Med Welt; 1974 Oct 04; 25(40):1589-92. PubMed ID: 4444495
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of chronic hepatitis.
    Mistilis SP, Lam KC.
    Prog Liver Dis; 1972 Oct 04; 4():419-32. PubMed ID: 4569006
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of chronic diseases of the liver].
    Loginov AS.
    Ter Arkh; 1977 Oct 04; 49(1):3-9. PubMed ID: 867234
    [No Abstract] [Full Text] [Related]

  • 18. [Blood coagulation activity in patients with chronic hepatitis and cirrhosis of the liver, treated with glucocorticoid hormones].
    Zlatkina AR, Levantovskaia OM, Kravtsova EF.
    Ter Arkh; 1972 Apr 04; 44(4):98-102. PubMed ID: 5051568
    [No Abstract] [Full Text] [Related]

  • 19. [Corticosteroid therapy in hepatic diseases].
    Mazzacca G.
    Recenti Prog Med; 1967 Jul 04; 43(1):51-70. PubMed ID: 4302862
    [No Abstract] [Full Text] [Related]

  • 20. [Combination of liver extracts with vitamin B complex and adrenal cortex hormones in liver cirrhosis and infectious hepatitis].
    ABBOZZO G.
    Minerva Med; 1956 Oct 06; 47(80):980-8. PubMed ID: 13387219
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.